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Abstract
Background: Colibacillosis caused by enterotoxigenic Escherichia coli (E. coli) results in economic losses in the poultry
industry. Antibiotics are usually used to control colibacillosis, however, E. coli has varying degrees of resistance to
different antibiotics. Therefore the use of probiotics is becoming accepted as an alternative to antibiotics. In this study,
we evaluated the effects of Clostridium butyricum (C. butyricum) on growth performance, immune response, intestinal
barrier function, and digestive enzyme activity in broiler chickens challenged with Escherichia coli (E. coli) K88.
Methods: The chickens were randomly divided into four treatment groups for 28 days. Negative control treatment
(NC) consisted of birds fed a basal diet without E. coli K88 challenge and positive control treatment (PC) consisted of
birds fed a basal diet and challenged with E. coli K88. C. butyricum probiotic treatment (CB) consisted of birds fed a diet
containing 2 × 107 cfu C. butyricum/kg of diet and challenged with E. coli K88. Colistin sulfate antibiotic treatment (CS)
consisted of birds fed a diet containing 20 mg colistin sulfate/kg of diet and challenged with E. coli K88.
Results: The body weight (BW) and average day gain (ADG) in the broilers of CB group were higher (P < 0.05) than the
broilers in the PC group overall except the ADG in the 14-21 d post-challenge. The birds in CB treatment had higher
(P < 0.05) concentration of tumor necrosis factor-α (TNF-α) at 3 and 7 d post-challenge, and higher (P < 0.05)
concentration of interleukin-4 (IL-4) at 14 d post-challenge than those in the PC treatment group. The concentration of
serum endotoxin in CB birds was lower (P < 0.05) at 21 d post-challenge, and the concentrations of serum diamine
oxidase in CB birds were lower (P < 0.05) at 14 and 21 d post-challenge than in PC birds. Birds in CB treatment group
had higher (P < 0.05) jejunum villi height than those in PC, NC, or CS treatment at 7, 14, and 21 d post-challenge. In
comparison to PC birds, the CB birds had lower (P < 0.05) jejunum crypt depth during the whole experiment. The birds
in CB or CS treatment group had higher (P < 0.05) activities of amylase and protease at 3, 7, and 14 d post-challenge,
and higher (P < 0.05) activity of lipase at 3, 7 d post-challenge than PC birds.
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Conclusions: In all, these results indicate that dietary supplementation with C. butyricum promotes immune response,
improves intestinal barrier function, and digestive enzyme activities in broiler chickens challenged with E. coli K88.
There is no significant difference between the C. butyricum probiotic treatment and the colistin sulfate antibiotic
treatment. Therefore, the C. butyricum probiotic may be an alternative to antibiotic for broiler chickens.
Keywords: Broiler chickens, Clostridium butyricum, Digestive enzyme activity, Escherichia coli K88, Growth performance,
Immune response, Intestinal barrier
Background
Colibacillosis caused by enterotoxigenic Escherichia coli
(E.coli) is a serious infection that results in huge eco-
nomic losses in the poultry industry worldwide [1–4].
Although antibiotics are usually used to control coliba-
cillosis, various reports have demonstrated that patho-
genic E. coli has varying degrees of resistance to
different antibiotics [5, 6]. Additionally, resistance genes
extended-spectrum beta-lactamases (ESBL) and/or
plasmid-mediated Amp-C beta-lactamases (Amp-C) in
commercial E. coli may pose a human health hazard. [7]
Therefore, there is an urgent need to identify sustainable
alternatives to antibiotics for animal production.
The use of probiotics in the poultry industry is quickly
becoming accepted as a potential alternative to antibi-
otics for use as growth-promoters, and in some cases,
for control of specific enteric pathogens [8–15].
Clostridium butyricum (C. butyricum) is a butyric-
acid producing Gram-positive anaerobe found in soil
and intestines of healthy animals and humans. C.
butyricum increases the concentrations of n-butyric
acid in caecaldigesta of birds [16], and butyric acid is
of particular importance because of its nutritional
properties for epithelial cells and pathogen inhibitory
effects in the gut [17]. C. butyricum also survives at
low pH and high temperature, which renders it a
good feed additive [18]. Previous studies
demonstrated that C. butyricum promoted growth
performance [16, 19–21], balanced intestinal micro-
flora [16, 17, 19, 20], improved intestinal morphology
[16, 19], stimulated the immune system [19, 20], im-
proved meat quality and fatty acid profiles [21–23],
and influenced the digestive tract [23] in broiler
chickens. In addition, C. butyricum prevented E.coli-
induced intestinal disorders through inhibiting E.coli
viability and mediating E.coli-induced apoptosis [24].
However, there are few published reports on the ef-
fects of C. butyricum on E.coli-challenged animals.
The present study was conducted to investigate the
effects of C. butyricum on the immune response, in-
testinal barrier function, and digestive enzyme activ-
ities in broiler chickens challenged with E. coli K88.
Methods
Ethics statement
All procedures were approved by the Institutional
Animal Care and Use Committee of Zhejiang University.
Birds, diets, and experimental design
Three hundred and sixty 1-d-old male Cobb broiler
chickens purchased from a commercial hatch (Charoen
Pokphand Group, Haining, China) were randomly
assigned to four treatment groups. Negative control
treatment (NC) consisted of birds fed a basal diet with-
out challenging with E. coli K88. Positive control treat-
ment (PC) consisted of birds fed a basal diet and orally
challenged with 0.5 mL E. coli K88 (2 × 108 cfu/mL) on
d 7. The C. butyricum treatment (CB) probiotic group
consisted of birds fed a diet containing 2 × 107 cfu C.
butyricum/kg of diet and orally challenged with 0.5 mL
E. coli K88 (2 × 108 cfu/mL) on d 7. Colistin sulfate
treatment (CS) antibiotic group consisted of birds fed a
diet containing 20 mg colistin sulfate/kg of diet and or-
ally challenged with 0.5 mL E. coli K88 (2 × 108 cfu/mL)
on d 7. Each treatment consisted of 6 replicate pens with
15 birds per pen. Birds in NC treatment were housed in
one room, while the birds in other three E. coli-chal-
lenged treatment groups were housed in another room
to prevent cross-contamination. The two rooms were of
the same configuration and the previous growth studies
revealed no significant contamination room effects.
Chickens were placed in the wire cages and all birds
were offered the same antibiotic-free basal diets and pro-
vided ad libitum access to water and diet. The nutrient
levels of the diets met the NRC (1994) broiler recom-
mendations (Table 1). The temperature was adjusted to
32 °C in the first week and gradually lowered to 25 °C.
The C. butyricum strain (HJCB998) was obtained
from Zhejiang Huijia Biological Technology Ltd., Anji,
China. The probiotic strain was grown anaerobically
in a liquid fermentation tank at 37 °C for 48 h, and
then the cells were harvested by centrifugation and
dried by spray-drying technology. Colistin sulfate was
obtained from Zhejiang Qianjiang Biochemical Ltd.,
Haining, China.
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Oral challenge
The E. coli K88 strain was obtained from College of
Animal Sciences, Zhejiang University (Hangzhou, China)
and grown at 37 °C. The birds in different treatments
were fed the corresponding diet for the first 6 d. On d 7,
birds in PC, CB, and CS treatments were orally fed with
0.5 mL (2 × 108 cfu/mL) E. coli K88 inoculants by using
a polyethylene tube attached to a syringe. The birds in
NC treatment were administered the same amount of
sodium chloride solution as control.
Sample collection
Birds were weighed individually at 3, 7, 14, and 21 d
post-challenge to evaluate BW and ADG. Feed con-
sumption and feed-to-gain ratio could not be deter-
mined because of an indeterminate amount of feed
wastage.
Six birds per treatment (1 bird per pen) were ran-
domly selected for sample collection at 3, 7, 14, and 21
d post-challenge. Blood samples were taken from the
wing vein and centrifuged (3,000 × g, 10 min) at 4 °C,
and then the serum was harvested and stored at -20 °C
until analysis. The birds were then killed by CO2 inhal-
ation and jejunum samples were collected. Two 1 cm
segments of jejunum were collected immediately after
slaughter. The segment was located in a distal segment
about 5 cm proximal to the duodenum. The surplus je-
junum section was gently flushed with phosphate-
buffered saline (PBS) and the mucosa was scraped from
the jejunum with a sterile blade and stored in a 1.5 mL
sterile microcentrifuge tube at -20 °C.
Mucosal cytokines
Jejunal mucosa (0.5 g per sample) was weighed out, di-
luted into 4.5 mL of 0.9 % salt solution, and centrifuged
at 6,000× g for 15 min. The homogenate was kept on
sterile ice and the supernatant was harvested into
1.5 mL sterile microcentrifuge tubes. The concentrations
of interleukin-4 (IL-4) and tumor necrosis factor-α
(TNF-α) were respectively measured using IL-4 (1042-
09) and TNF-α (1041-09) ELISA kits (GBD Ltd, USA)
specific for chicken.
Serum endotoxin and diamine oxidase
The concentrations of serum endotoxin were measured
using a limulus amoebocyte lysate (LAL)-based kit (LAL
QCL-1000 kit, Lonza, Walkersville, MD). The samples
were heated for 10 min at 70 °C. Internal control for re-
covery calculation was included in the assessment. Stan-
dards and samples were incubated for 10 min at 37 °C
with LAL and then for another 6 min with colorimetric
substrate. The reaction was stopped with 25 % acetic
acid and then the absorbance was read at 405 nm. Di-
amine oxidase (DAO) activity (1 ml) was examined by a
spectrophotometric assay. The DAO standard (batch
number D7876-250) was purchased from Sigma.
Jejunalmorphology analysis
Jejunal segments were flushed with a 0.9 % salt solution,
and then fixed with 10 % formaldehyde-phosphate buffer
for 48 hours. The formalin-fixed, paraffin-embedded tis-
sues were embedded into Leica EG1160, fixed upon
Rotary Microtome (Leica RM2153) and then cut to a
thickness of 6 μm. The tissue segments were dehydrated
with Leica HI1220. Slides were stained with hematoxylin
and eosin (H&E; Leica Autostain BRXL) and covered by
cover slides. Images were analyzed using software Qwin.
Then the 10 longest jejunal villi and lowest jejunal crypts
were measured with Olympus AX70 microscope (Olym-
pus Corporation, Tokyo, Japan) and the mean value was
calculated. The villus height was measured from the
villus-crypt junction to the tip of villus, whereas crypt
depth was measured from the root of villus to the lam-
ina propria.
Digestive enzyme activities
Amylase, lipase, and protease were analyzed using the
corresponding kit provided by Jiancheng Bioengineering
Institute (Nanjing, China). In brief, the jejunal mucosa
was transferred into sterilized tubes containing 10 mL
PBS (7.4 pH), then ultrasonic treatment was applied for
4 min to dissociate the tissues. The later procedure was
accomplished by centrifugation (5,000 × g for 25 min).
Then the supernatant was used to determine the enzym-
atic activities following the manufacturer’s instructions.
Table 1 The composition and nutrients of basal dieta
Ingredient Content, % Chemical composition Content
Corn 55.23 CP, % 20.90
Soybean meal 30.67 ME, Mcal/kg 3.00
Wheat shorts 4.00 Calcium, % 1.00
Fish mealb 3.00 Total P, % 0.65
Soybean oilc 2.90 Available P, % 0.45
DL-Methionine 0.27 Methionine +
cysteine, %
0.90




aNutrient level of the diets was based on NRC (1994)
bCrude protein content is 62.5% and metabolizable energy is 2.79 Mcal/kg
cMetabolizable energy is 8.8 Mcal/kg
dSupplied per kilogram of diet: vitamin A(retinyl acetate), 1,500 IU;
cholecalciferol, 200 IU; vitamin E(DL-α-tocopheryl acetate), 10 IU; riboflavin, 3.5
mg; pantothenic acid, 10 mg; niacin, 30 mg; cobalamin, 10μg; choline chloride,
1,000 mg; biotin, 0.15 mg; folic acid, 0.5 mg; thiamine 1.5 mg; pyridoxine 3.0
mg; Fe, 80 mg; Zn, 40 mg; Mn, 60 mg; I, 0.18 mg; Cu, 8 mg; Se, 0.15 mg
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Statistical analysis
One-way ANOVA was performed using SPSS 16.0 Soft-
ware. Mean values of treatment groups were compared
using Duncan’s multiple range test with P < 0.05 consid-
ered statistically significant.
Results
Birds in the PC (positive control) treatment group had
less (P < 0.05) BW than the NC (negative control), CB
(C. butyricum), and CS (colistin sulfate) birds from 3 to
21d post-challenge (Table 2). There were no significant
differences among the BW of NC, CB, and CS groups.
The birds of CB group had higher ADG than those fed
the PC diet during 3-7, 7-14, and 3-21 d post-challenge.
No significant differences in BW and ADG were observed
among the birds of NC, CB, and CS groups except that
the ADG of CB and CS broilers was higher than the
broilers of the NC groups in 3-7 d post-challenge.
Birds in CB treatment had higher (P < 0.05) concentra-
tion of jejunal mucosa TNF-α than those in NC or PC
treatment at 3 d post-challenge, and higher (P < 0.05)
concentration of TNF-α than PC birds at 7 d post-
challenge (Table 3). There was no significant difference
in the concentration of TNF-α between CB and CS birds
during the whole experiment. In comparison to PC
birds, CB birds had greater (P < 0.05) concentration of
jejunal mucosa IL-4 on 14 d post-challenge. No signifi-
cant differences were observed in the concentration of
IL-4 among CB, NC, and CS treatments during the
whole experiment.
The E. coli challenge significantly increased the
concentration of serum endotoxin during the whole
experiment (Table 4). Birds in CB treatment had lower
(P < 0.05) serum endotoxin at 21d post-challenge com-
pared with PC birds. There were no significant differ-
ences in the concentrations of serum endotoxin between
CB and CS treatment during the whole experiment. The
E. coli challenge significantly increased the concentration
of serum DAO during the entire experimental period.
Birds in CB treatment had lower (P < 0.05) concentration
of serum DAO than those in PC treatment at 14 and 21
d post-challenge. No significant differences were found
in the concentration of serum DAO between CB and CS
treatment group during the course of the experiment.
Birds fed CB had higher (P < 0.05) jejunum villi height
than PC, NC, or CS birds at 7, 14, and 21 d post-
challenge (Table 5). In comparison to the broilers in PC
treatment, broilers in CB treatment had lower (P < 0.05)
jejunum crypt depth throughout the experiment. Birds
fed CS had lower (P < 0.05) jejunum crypt depth com-
pared to PC birds at 7, 14, and 21 d post-challenge.
The E. coli challenge significantly decreased the activ-
ity of jejunal mucosa amylase; however, broilers fed with
CB or CS had increased (P < 0.05) amylase activity




NC PC CB CS SEM P-value
BW, g 3d 351.71a 319.83b 342.23a 339.95a 3.588 <0.01
7d 401.16a 354.00b 402.71a 398.81a 4.479 <0.01
14d 747.33ab 649.00c 774.83a 738.16b 11.161 <0.01
21d 1283.5a 1064.8b 1265.8a 1275.2a 26.491 <0.01
ADG, g 3-7d 12.36b 8.54c 15.12a 14.71a 0.651 <0.01
7-14d 49.45a 42.14b 53.16a 48.47a 1.117 <0.01
14-21d 76.60 59.40 70.13 76.72 2.831 0.089
3-21d 51.76a 41.38b 51.30a 51.95a 1.365 <0.01
a-cMeans in the same row with different superscript letters differ significantly (P < 0.05)
1Each mean represents 6 birds. NC = birds fed a basal diet without challenged with E. coli K88; PC = birds fed a basal diet and challenged with E. coli K88.
CB = birds fed a basal diet including 2 × 107 CFU C. butyricum/kg of diet and challenged with E. coli K88. CS = birds fed a basal diet including 20 mg colistin
sulfate/kg of diet and challenged with E. coli K88
2The days after challenging





NC PC CB CS SEM P-value
TNF-α, ng/L 3d 53.80b 48.88b 76.66a 65.09ab 7.19 0.030
7d 65.29ab 53.88b 69.32a 61.51ab 4.72 0.040
14d 63.39 50.22 62.92 61.23 6.88 0.220
21d 50.56 35.28 54.46 56.92 6.92 0.110
IL-4, ng/L 3d 52.52 50.9 68.7 67.51 5.78 0.140
7d 68.23a 52.16b 62.91ab 57.03ab 3.55 0.030
14d 70.65a 50.46b 69.79a 59.78ab 4.26 0.010
21d 52.64 42.59 56.38 57.09 6.41 0.350
a-cMeans in the same row with different superscript letters differ
significantly (P < 0.05)
1Each mean represents 6 birds. NC = birds fed a basal diet without challenged
with E. coli K88; PC = birds fed a basal diet and challenged with E. coli K88.
CB = birds fed a basal diet including 2 × 107 CFU C. butyricum/kg of diet and
challenged with E. coli K88. CS = birds fed a basal diet including 20 mg colistin
sulfate/kg of diet and challenged with E. coli K88
2The days after challenging
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compared with broilers in the PC treatment group from
3 to 14 d post-challenge (Table 6). No significant differ-
ences were found in the activities of amylase between
CB and CS treatments during the whole experiment.
Compared with PC birds, the birds in CB or CS treat-
ments had higher (P < 0.05) activities of protease from
3 to 14 d post-challenge. There were no significant
differences in the activity of protease among the four
treatment groups at 21 d post-challenge. Moreover,
there were no significant differences between CB and
NC treatments in the activity of lipase at 3 and 7 d
post-challenge, but those two treatment groups had
higher (P < 0.05) activity of lipase than PC treatment;
and no significant differences in the activity of lipase
among the four treatments at 14 and 21 d post-
challenge.
Discussion
Many reports have showed that probiotics can promote
growth performance and improve nutrient utilization ef-
ficiency in chickens [6, 25–27], although other studies
have also reported that probiotics have no effect on
growth performance [28–30]. In contrast, Clostridium
butyricum is a probiotic that has been shown to improve
growth performance and nutrient utilization efficiency in
chickens [20, 21, 31] although Zhang et al. reported that
C. butyricum had no effect on broiler performance [16].
In this study we showed that C. butyricum improved the
BW and ADG of chickens challenged with E. coli K88
compared with broilers in the PC group, and the broilers
in the CB group showed no significant differences com-
pared to the CS groups on the BW and ADG overall.
Previous reports had shown that probiotics stimulate
the immune response [20, 27, 32–34]. Specifically, C.
butyricum has been shown as capable of influencing the
host immune system by modulating cytokine expression
[19, 35–37]. C. butyricum could induce the sensitization
of the host by increasing pro-inflammatory cytokines
such as IL-8, IL-6, and TNF-α, and provide beneficial ef-
fects to the host by synthesizing the immunosuppressive
cytokines such as IL-10 [19, 36, 37]. IL-4 and TNF-α
were also secreted by an intracellular signaling cascade
in the immune response in response to C. butyricum
[38]. Huang et al. [39] reported that Bacillus induced
TNF-α in spleens and mesenteric lymph nodes of mice
[39]. Lee et al. [30] showed that IL-4 transcripts were in-
creased by B. subtilis strains LSSAO1, Bs278, and Avi-
corr in broiler chickens [30]. However, Fujiwara et al.
[28] reported that supplementation with Bacillus subtilis
var. natto fermented soybean did not affect IL-4 gene ex-
pression in spleens in broiler chickens [28]. In the
present study, chickens fed with C. butyricum had
higher concentrations of TNF-α and IL-4. This indicated
Table 4 Effects of Clostridium butyricum on the concentrations




NC PC CB CS SEM P-value
Endotoxin,
EU/mL
3d 0.460b 0.738a 0.704a 0.734a 0.025 <0.01
7d 0.455b 0.640a 0.586a 0.578a 0.027 <0.01
14d 0.327b 0.413a 0.335ab 0.347ab 0.024 0.070
21d 0.252c 0.380a 0.304bc 0.332ab 0.023 <0.01
DAO, U/mL 3d 2.559b 8.823a 7.493a 8.056a 0.498 <0.01
7d 1.570b 8.649a 7.121a 7.496a 0.617 <0.01
14d 1.250c 6.254a 4.194b 4.201b 0.527 <0.01
21d 0.819c 3.952a 2.419b 3.060ab 0.424 <0.01
a-cMeans in the same row with different superscript letters differ
significantly (P < 0.05)
1Each mean represents 6 birds. NC = birds fed a basal diet without challenged
with E. coli K88; PC = birds fed a basal diet and challenged with E. coli K88.
CB = birds fed a basal diet including 2 × 107 CFU C. butyricum/kg of diet and
challenged with E. coli K88. CS = birds fed a basal diet including 20 mg colistin
sulfate/kg of diet and challenged with E. coli K88
2The days after challenging




NC PC CB CS SEM P-value
Villi height, μm 3d 264.35 259.81 275.71 253.01 5.69 0.220
7d 267.65bc 287.54b 346.75a 254.41c 7.91 <0.01
14d 397.49b 355.07c 448.51a 410.9b 8.24 <0.01
21d 429.41b 433.6b 531.09a 407.26b 9.37 <0.01
Crypt depth, μm 3d 50.22a 47.01ab 33.68c 42.9b 2.08 <0.01
7d 50.06b 60.3a 39.44c 38.2c 2.17 <0.01
14d 66.07b 73.96a 56.51c 59.95c 1.87 <0.01
21d 82.5b 115.46a 84.04b 76.03b 3.29 <0.01
a-cMeans in the same row with different superscript letters differ significantly (P < 0.05)
1Each mean represents 6 birds. NC = birds fed a basal diet without challenged with E. coli K88; PC = birds fed a basal diet and challenged with E. coli K88.
CB = birds fed a basal diet including 2 × 107 CFU C. butyricum/kg of diet and challenged with E. coli K88. CS = birds fed a basal diet including 20 mg colistin
sulfate/kg of diet and challenged with E. coli K88
2The days after challenging
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that C. butyricum influenced the immune response in
broiler chickens challenged with E. coli K88.
Lipopolysaccharide (LPS) is an integral component of
the outer cell membranes of Gram-negative bacteria
which are shed from the bacteria when cell lysis occurs
[40]. E. coli K88 produces LPS [41], which induced en-
dotoxic shock by triggering the systemic inflammatory
response [42–45]. The endotoxins from LPS induce a
degenerative morphology and the destruction of lym-
phocytes in birds [46]. Moreover, endotoxin is associated
with intestinal permeability [47–49].When gut perme-
ability is increased, the endotoxin will translocate from
the gut into circulation. Ait-Belgnaoui et al. [48]
reported that L. farciminis treatment prevented stress-
induced peripheral endotoxin in rats [48]. DAO is local-
ized mainly in the small intestinal mucosa, particularly
near the tips of villi and reflects small intestinal integrity
and maturity [50–52]. Intestinal mucosal damage causes
leakage of DAO from small intestinal villus tips into the
circulation, so DAO is an index of intestinal mucosal
barriers [52–54]. Zhang et al [35] reported that the
serum level of DAO in allergic mice was markedly
higher than that in control mice [35]. Synbiotic therapy
prevented HR-related decrease of intestinal integrity that
was indicated by the reduction in serum DAO activity
[55] and returned serum DAO activities to normal levels
after hepatectomy in humans [56]. Zhou et al. reported
that Lactobacillus plantarum significantly lowered the
plasma DAO activities in the bile duct ligation rat model
[57]. Sun et al [58] reported that probiotics relatively de-
creased the levels of LPS and DAO in rats compared
with the cardiopulmonary bypass (CPB)-operated ones
[58]. In this study, dietary supplementation of C. butyri-
cum decreased serum endotoxin and DAO in E. coli-
challenged birds. Our results indicated that CB benefits
the intestinal barrier function in broiler chickens chal-
lenged with E.coli K88.
The length of villi and the depth of crypt are the im-
portant morphological parameters, and are considered
as indicators of optimal intestinal functions. The previ-
ous studies showed that dietary supplementation with
probiotics increased the villus height and villus height:
crypt depth ratio, decreased the crypt depth in broiler
chickens [59–64]. Our previous research also showed
that birds fed C. butyricum had higher ileal villus height
and lower ileal crypt depth [31]. The present study
showed that dietary supplementation with CB increased
the jejunal villus height and decreased the crypt depth in
broiler chickens challenged with E.coli K88. The current
result demonstrated that C. butyricum improved the
structure and function of intestinal mucosa in E.coli in-
fected condition.
Amylase, lipase, and protease play very important roles
in the digestion of nutrient materials. Reports on the ef-
ficacy of probiotics on the digestive enzymes have been
varied. Rajput et al. [34, 65] reported that Saccharomyces
boulardii supplementation increased the activity of lip-
ase, but had no significant improvement in amylase and
trypsin in the jejunum of broiler chickens [65]. Wang
and Gu [26] reported that the probiotic Bacillus coagu-
lans NJ0516 increased the activities of protease and
amylase but had no effect on the activities of lipase in




NC PC CB CS SEM P-value
Amylase, U/mgprot 3d 0.94a 0.33c 0.70b 0.74ab 0.058 <0.01
7d 0.96a 0.45b 0.88a 0.83a 0.054 <0.01
14d 0.80a 0.60b 0.87a 0.78a 0.033 0.018
21d 0.91a 0.75b 0.79ab 0.85ab 0.027 0.112
Protease, U/mgprot 3d 106.86a 54.66c 76.92b 80.10b 5.080 <0.01
7d 103.76a 65.29b 93.32a 89.39a 4.213 <0.01
14d 98.17a 67.04b 93.60a 91.46a 3.975 0.014
21d 130.76 109.06 133.03 125.01 4.648 0.264
Lipase, U/mgprot 3d 190.87ab 105.14c 154.02b 205.53a 10.833 <0.01
7d 193.84a 105.66b 186.09a 155.90ab 10.800 <0.01
14d 183.76 167.93 205.40 195.76 7.046 0.278
21d 194.07 177.85 197.87 203.41 5.697 0.448
a-cMeans in the same row with different superscript letters differ significantly (P < 0.05)
1Each mean represents 6 birds. NC = birds fed a basal diet without challenged with E. coli K88; PC = birds fed a basal diet and challenged with E. coli K88.
CB = birds fed a basal diet including 2 × 107 CFU C. butyricum/kg of diet and challenged with E. coli K88. CS = birds fed a basal diet including 20 mg colistin
sulfate/kg of diet and challenged with E. coli K88
2The days after challenging
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broilers [26]. However, de Lima et al. [29] reported that
the addition of the probiotic Bacillus subtilis in the diet
did not affect digestive enzymes activities in broiler
chickens [29]. The present study indicated that dietary
supplementation of C. butyricum promoted digestive en-
zyme activities in broiler chickens challenged with E. coli
K88. This was likely due to C. butyricum-induced pro-
tection of the intestinal integrity by inhibiting the activ-
ities of E. coli K88 and LPS, so augmented the activities
of these enzymes. It is also possible that C. butyricum is
capable of directly producing digestive enzymes in the
gut of animals.
Conclusion
The results of our study indicated that E. coli K88 chal-
lenge lowered the BW and ADG, decreased the intes-
tinal barrier function and digestive enzyme activities, but
dietary supplementation of C. butyricum reversed these
observations and promoted the immune response, im-
proved intestinal barrier function and digestive enzyme
activities in broiler chickens challenged with E. coli K88.
Our results suggest that including C. butyricum in
poultry diets has the potential for rearing healthier birds.
There was no significant difference between the C.
butyricum probiotic treatment and the colistin sulfate
antibiotic treatment on the effect of growth performance,
immune response, intestinal barrier function, and digest-
ive enzyme activity in broiler chickens challenged with
Escherichia coli. Therefore, the C. butyricum probiotic
may be an alternative to antibiotic for animal production.
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